DOI:10.32604/biocell.2021.015297
www.techscience.com/journal/biocell
| Biocell DOI:10.32604/biocell.2021.015297 | www.techscience.com/journal/biocell |
| Article |
SOD1G93A Induces a Unique PSAP-Dependent Mitochondrial Apoptosis Pathway via Bax–Bak Interaction
1Edmond H. Fischer Signal Transduction Laboratory, College of Life Sciences, Jilin University, Changchun, 130012, China
2Scientific Research Centre of China-Japan Union Hospital, Jilin University, Changchun, 130033, China
3Department of Biology, College of Arts and Sciences, University of Texas of the Permian Basin, Odessa, TX 79762, USA
4Department of General Surgery, The Second Hospital of Jilin University, Changchun, 130041, China
5School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China
*Address correspondence to: Fuqiang Zhang, zfqzhang@jlu.edu.cn; Linlin Zeng, zenglinlin@jlu.edu.cn
Received: 08 December 2020; Accepted: 18 February 2021
#These authors contributed equally to this work
Abstract: Amyotrophic lateral syndrome (ALS) is a progressive degenerative disorder characterized by motor neuron death and axon degeneration. Mitochondrial dysfunction plays a key role in the pathogenesis of ALS, the mechanism of which remains poorly understood. The B-cell lymphoma-2 (Bcl-2) family of proteins that control and mediate mitochondrial function and apoptosis, including the pro-apoptotic members Bcl2-Associated X (Bax), are involved in ALS development. The death receptor 6 (DR6) regulates motor neuron death in ALS, and DR6 antibodies can prevent axon degeneration and motor neuron damage by blocking DR6. Previous studies demonstrated that PSAP localized to mitochondria and was required for DR6-induced apoptosis. In this study, SOD1G93A was transfected into the motor neuron cell line NSC-34 to serve as an ALS cell model in vitro. The data assessed the role of PSAP in SOD1G93A-induced apoptosis and demonstrated that the overexpression of SOD1G93A, but not wtSOD1, induced PARP cleavage, caspase-3 activation, cytochrome c release, and Bax translocation. PSAP, Bax, and Bak were necessary for SOD1G93A-induced apoptosis, as silencing PSAP inhibited SOD1G93A-mediated cell death that was dependent on Bax–Bak interaction.
Keywords: ALS; Bax; Mitochondria; PSAP; SOD1G93A
Amyotrophic lateral syndrome (ALS) is a progressive neuronal degenerative disease that causes damage to motor neurons.
ALS can be divided into familial (fALS) and sporadic ALS (sALS) (Wang et al., 2018). fALS accounts for 5–10% of the total number of ALS cases. Mutations in superoxide dismutase 1 (SOD1) account for ~20% of fALS and ~5% of sALS (Alonso et al., 2009). The motor neurons in the brain, brainstem, and spinal cord of patients with ALS are invaded; therefore, the muscles undergo atrophy, weakness, and even paralysis. The onset and early progression of ALS are usually insidious, and neurologists often fail to identify ALS during early disease stages. Following disease progression, up to ~80% of motor neurons are lost when clinical signs of weakness appear (Pasinelli and Brown, 2006). Unfortunately, the etiology of ALS remains unknown. Generally, wild-type SOD1 (wtSOD1) is located in the cytosol, and mutant forms are found within the mitochondria of ALS neurons. SOD1 mutation is the most studied factor in ALS. It is found in about a quarter of fALS cases, and 7% of common sALS cases and human mutSOD1G93A-transgenic mice showed the typical phenotypes of patients with ALS in the clinic.
Mitochondrial dysfunction is critical in the pathogenesis of neurodegenerative disorders, such as ALS and Alzheimer’s disease (Chaturvedi and Beal, 2013). Mitochondrial homeostasis regulates neuronal apoptosis via the intrinsic pathway. Indeed, pro-apoptotic members of the Bcl-2 family, such as Bak and Bax, induce mitochondrial cytochrome c (Cyt C) release from the mitochondria into the cytosol, promoting apoptosome formation, including cytoplasmic apoptotic protease activating factor-1 (Apaf-1), Cyt C, and caspase-9, which activates downstream caspases that induce apoptosis (Xu et al., 2017). The decreased expression of anti-apoptotic members of the Bcl-2 family, including Bcl-xl, coupled to the increased expression of Bcl-2-associated death domain (Bad) and Bax, is frequently observed in transgenic SOD1G93A mice and patients with ALS. The interaction of mutant SOD1 and Bcl-2 can trigger mitochondrial-dependent neuronal death in ALS. In addition, Bcl-2 overexpression can rescue motor neurons in fALS (Chen et al., 1997). The number of damaged motor neurons, the rescue of axonal degeneration, and muscle and movement activity significantly improved in Bax−/− or P53 up-regulated modulator of apoptosis (Puma−/−) mice (Gould et al., 2006; Kieran et al., 2007). However, how mitochondrial dysfunction regulates motor neuron death in ALS remains unknown.
Elevated DR6 protein levels have been detected in SOD1G93A mice and patients with ALS. DR6 antibodies can inhibit motor neuron death via blocking DR6, highlighting the role of DR6 in ALS (Huang et al., 2013). Xu et al. (2017) identified presenilin 1 (PS1)-associated protein (PSAP) through its interaction with PS1 via the double yeast hybrid system (Mao et al., 2008; Cozzolino et al., 2013). PSAP was specifically located in the mitochondria and was required for DR6-induced apoptosis (Zhang et al., 2020). This study investigated the role of PSAP in SOD1G93A-induced apoptosis in the mouse motor neuron cell line NSC-34.
The present study demonstrated that SOD1G93A overexpression in NSC-34 cells led to the induction of apoptosis. The knockdown of PSAP, Bax, or Bak abolished PARP cleavage and caspase 3 activation, induced by SOD1G93A, indicating that PSAP, Bax, and Bak mediated cell death following SOD1G93A overexpression. Furthermore, the immunoprecipitation (IP) analysis showed that PSAP interacted with Bax and Bak on SOD1 overexpression. In addition, PSAP was required for SOD1G93A-induced apoptosis, which was dependent on Bax–Bak complex formation.
Lipofectamine 2000 was purchased from Thermo Fisher (CA, USA). A mitochondria isolation kit was procured from Transgen Biotech (Beijing, China). Complete protease inhibitor cocktail tablets, Cell Counting Kit-8 (CCK-) 8, and anti-Cyt C antibody were purchased from Bimake (TX, USA). Anti-myc, Bak, β-actin, and Cox I antibodies, were purchased from Santa Cruz Biotechnology (TX, USA). An anti-PARP antibody was purchased from Cell Signaling Technology (MA, USA). An anti-Bax antibody was purchased from R&D Systems (MN, USA). Both anti-mouse IgG and anti-rabbit IgG secondary antibodies were purchased from Bioss (Beijing, China). pcDNA3.1/LacZ-Myc-Flag, pcDNA3.1/SOD1-Myc-Flag, and pcDNA3.1/SOD1G93A-Myc-Flag plasmids were amplified as described previously (Zeng et al., 2012).
NSC-34 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Hyclone) supplemented with fetal bovine serum (10%), streptomycin (100 μg/mL), and penicillin (100 units/mL) at 37°C and in the presence of 5% CO2. The cells were transfected with pcDNA3-LacZ, wtSOD1, or SOD1G93A constructs using Lipofectamine 2000 following the manufacturer’s protocols.
The cell survival activity was measured by the CCK-8 method. Briefly, NSC34 cells were seeded into 24-well plates at a density of 105 cells/mL. The cells were transfected with LacZ, wtSOD1, or SOD1G93A plasmids for 24 h. After 24 h-transfection, the CCK-8 reagent was added and cultured for 0.5–5 h at 37°C. The absorbance was finally measured at 450 nm following the manufacturer’s protocols.
A caspase-3 activity kit was purchased from Bioworld (Nanjing, China). NSC34 cells were seeded into six-well plates at a density of 5 × 105 cells/mL. The cells were transfected with LacZ, wtSOD1, or SOD1G93A plasmids for 24 h. Activated caspase-3 cleaved Ac-DEVD-pNA to generate pNA. The absorbance was measured at 405 nm to indicate caspase-3 activity.
siRNA duplexes to PSAP, Bax, and Bak, and scrambled siRNA and RNAi-mate reagent were purchased from Gene Pharma (Shanghai, China). The cells were treated with each siRNA for 48 h and transfected with LacZ, wtSOD1, or SOD1G93A plasmids using Lipofectamine 2000 reagent. The cells were harvested and lysed for further analysis 24 h after transfection.
Subcellular fractionation and mitochondrial preparation
The cytosolic and mitochondrial fractions were extracted using the mitochondria isolation kit following the manufacturer’s protocols to explore Cyt C release and Bax translocation.
Cell apoptosis was determined using an Annexin V/propidium iodide (PI) kit and analyzed by flow cytometry. The cells were harvested after 24 h transfection, washed twice with an ice-cold phosphate-buffered solution (PBS), and stained with Annexin V/PI solution.
IP and immunoblotting were performed as previously described (Zeng et al., 2012).
For Western blot analysis, cells were harvested and lysed by sonication for 25 s on ice in lysis buffer. Denatured protein (20 μg) ofeach sample was separated by SDS-PAGE and transferred to a polyvinylidene fluoride (PVDF) membrane. The PVDF membrane was blocked with 5% skim milk powder in Tris-buffered saline tween (TBST) for 45 min. The protein blot was then incubated with appropriate primary antibodies and HRP-conjugated secondary antibody separately. For immunoprecipitation (IP), cells were harvested and lysed by sonication for 20 s on ice in IP lysis buffer, and samples were centrifuged at 14,000 × g for 5 min at 4°C. Then the supernatants were incubated with anti-myc, anti-PSAP, or anti-Bax together overnight at 4°C. The samples were added with protein A-sepharose (Bimake, TX, USA) for 2 h. After washing five times with cold PBS, the immunoprecipitates were separated by SDA-PAGE and incubated with the primary antibodies.
The data were analyzed by using SPSS 22.0 statistical analysis software, and groups of data are presented as mean ± standard deviation (SD).Statistical significance was performed on the data by analysis of variance for significance test. **P < 0.01 was used as the criterion for determining statistical difference.
SOD1G93A overexpression induced apoptotic cell death in NSC-34 cells
NSC-34 cells were transfected with flag-tagged LacZ or wtSOD1, SOD1G93A to investigate whether SOD1G93A promoted apoptosis. Fig. 1A shows the percentage of viable cells after the transfection of LacZ, wtSOD1, and SOD1G93A. The results indicated that the overexpression of SOD1G93A decreased cell survival by ~45% compared with lacZ- or wtSOD1-transfected cells (P < 0.01).
As shown in Figs. 1B and 1C, SOD1G93A triggered PARP cleavage after 24 h-transfection. In contrast, no apoptotic events were observed on the transfection of LacZ or wtSOD1 constructs. Annexin V/PI double staining assay was performed to detect cells in the necrotic or apoptotic stage to further confirm the apoptotic activity of SOD1G93A. As shown in Fig. 1D, the number of apoptotic and necrotic cells was ~40% (B2 and B4) in SOD1G93A-transfected cells, while 5% of cells were B4 (Annexin V+/PI−) or B2 (Annexin V+/PI+) in LacZ- or wtSOD1-transfected cells, suggesting low levels of cell death. Taken together, these results strongly suggested that the overexpression of SOD1G93A induced apoptosis in NSC-34 cells.
Figure 1: SOD1G93A overexpression induced apoptotic cell death in NSC-34 cells. (A) NSC-34 cells were transfected with LacZ, wtSOD1, and SOD1G93A for 24 h, and the cell viability was assessed using CCK-8 assay. Experiments were performed in triplicate. Data represent the mean ± standard deviation. **P < 0.01, significant difference between SOD1G93A-transfected and LacZ-transfected groups. (B) Top panel: PARP; Panel 2: wtSOD1 or SOD1G93A-flag. β-actin was used as a loading control. (C) Experiments were performed in triplicate. Data represent the mean ± standard deviation. **P < 0.01, significant difference between SOD1G93A-transfected and LacZ-transfected groups. (D) Percentage of apoptotic cells was determined in LacZ-, wtSOD1-, and SOD1G93A-transfected cells using Annexin V/PI staining and flow cytometry analysis.
SOD1 G93A -induced apoptosis was mediated in Cyt C release and Bax translocation
Since mitochondrial damage promotes motor neuron cell death, the study next examined whether SOD1G93A induced the release of mitochondria-related molecules into the cytoplasm. As shown in Fig. 2, increased levels of Cyt C were detected in cytosolic extracts, while a concomitant decrease in the levels of these molecules was observed in the mitochondrial fractions on SOD1G93A overexpression (P < 0.01). In contrast, Bax expression reduced in the cytosolic fractions and was higher in the mitochondrial fraction on exogenous SOD1G93A expression (P < 0.01).
Figure 2: SOD1G93A-induced apoptosis involved cytochrome c release and Bax translocation. LacZ, wtSOD1, or SOD1G93A were transiently transfected for 24 h. The cells were then subjected to cytosolic (left panels) and mitochondrial extractions (right panels) as described under “Experimental Procedures.” Top panel: Cyt c release. Panel 2: Bax translocation. Panel 3: Bak release. Panel 4: β-actin. Bottom panel: COX I was only detected in the mitochondrial fraction, confirming the accuracy of the experimental procedures.Data presented as mean ± SEM. ANOVA, **P < 0.01 compared with control.
Silencing of Bax and Bak attenuated SOD1G93A-induced apoptosis
SOD1G93A triggered Cyt C release and Bax translocation regulated by the Bcl-2 family of proteins, which are known regulators of the mitochondrial apoptotic pathway. The study therefore determined the effects of Bax and Bak on SOD1G93A-induced apoptosis. Prior to SOD1G93A overexpression, the cells were silenced with Bax, Bak-specific siRNAs, or scrambled controls. The cell viability was then assessed following the transfection of LacZ, wtSOD1, and SOD1G93A. Fig. 3A shows that both Bax and Bak were involved in SOD1G93A-induced apoptosis as their silencing enhanced NSC-34 cell viability compared with nonsilencing cells (P < 0.01). As shown in Fig. 3B, SOD1G93A increased the activity of caspase-3 by ~40% compared with LacZ-transfected cells. However, SOD1G93A-triggered caspase-3 activation was inhibited by Bax or Bak silencing.Furthermore, as shown in Figs. 3C, 3E, and 3F, SOD1G93A-induced PARP cleavage was completely ablated following Bax or Bak silencing. The effect of Bax- or Bak-silenced cells on SOD1G93A overexpression-induced cell death was confirmed by Annexin V/PI staining (Fig. 3G), indicating that the percentage of apoptotic cells was ~60% (B2 and B4) following SOD1G93A overexpression, which decreased to ~10% in Bax- or Bak-silenced cells. These data indicated that both Bax and Bak were required for SOD1G93A-induced apoptosis.
Figure 3: Silencing of Bax, Bak, and PSAP attenuated SOD1G93A-induced apoptosis. As indicated, NSC-34 cells were transiently transfected with LacZ, wtSOD1, or SOD1G93A, respectively, 48 h after the transfection of scrambled Bax-, Bak-, and PSAP-specific siRNAs. (A) The cells were harvested for CCK-8 assays. Experiments were performed in triplicate. Data represent the mean ± standard deviation. **P < 0.01. (B) Caspase-3 activity in cells treated with specific siRNAs to Bax, Bak, or PSAP on SOD1G93A transfection using caspase-3 activity detection kits. (C) Top panel: knockdown efficiency of Bax, Bak, and PSAP. Second panel: probed with anti-PARP antibodies. Third panel: transfection efficiency of SOD1G93A using anti-flag antibodies. Bottom panel: β-actin as a loading control. (D), (E), and (F) Data are presented as mean ± SEM. ANOVA, *P < 0.05, **P < 0.01 compared with control. (D) for Bax, (E) for Bak, (F) for PSAP. (G) Percentage of apoptotic cells determined following LacZ, SOD1, and SOD1G93A transfection on Bax, Bak, or PSAP silencing using Annexin V/PI staining and flow cytometry analysis.
PSAP silencing abolished SOD1G93A-induced apoptosis
PSAP specifically localized to the outer membrane of the mitochondria and was associated with Bax or Bak. In addition, PSAP was required for DR6-induced apoptosis (Zhang et al., 2020). DR6 was highly expressed in samples from mice and patients with ALS and played a crucial role in ALS development. The effects of DR6 on PSAP-specific siRNAs were assessed to further determine the role of PSAP in SOD1G93A-induced apoptosis. Similarly, the silencing of PSAP attenuated SOD1G93A-triggered cell death (Fig. 3A), PARP cleavage (Figs. 3C and 3F), and caspase-3 activation (Fig. 3B). Annexin V/PI staining confirmed these effects. Taken together, these data revealed that PSAP was required for SOD1G93A-induced apoptosis (Fig. 3G).
PSAP regulated SOD1G93A-induced apoptosis through Bax–Bak binding
The possible interaction of Bax, Bak, and PSAP upon SOD1G93A overexpression was explored to further investigate the mechanism by which Bax, Bak, and PSAP mediated SOD1G93A-induced apoptosis. As shown in Fig. 4A, Bax co-immunoprecipitated with SOD1-myc using anti-myc antibodies (lanes 3 and 4, top panel) but not IgG (lane 5) on transfection with wtSOD1 or SOD1G93A. The levels of this complex modestly decreased in SOD1G93A-transfected cells (lane 4) compared with wtSOD1-transfected cells (lane 3). Similarly, Bak co-immunoprecipitated with anti-myc (SOD1), but the interaction did not increase in cells overexpressing SOD1G93A. Furthermore, only a negligible change in the levels of PSAP–Bax or PSAP–Bak complex formation was observed on SOD1G93A transfection compared with LacZ-transfected cells. On transfection with wtSOD1, Bax co-immunoprecipitated with PSAP, while PSAP–Bak complex formation decreased. In addition, Bak–Bax complexes were detected in SOD1G93A-expressing cells (lanes 4 and 5). The effects on PSAP-specific siRNAs were assessed to further confirm the role of PSAP in SOD1G93A-induced Bak–Bax interaction. Similarly, the silencing of PSAP (Figs. 4C and 4D) attenuated SOD1G93A-triggered Bak–Bax complex formation (lane 7 compared with lane 4, Fig. 4B). These data indicated that PSAP regulated SOD1G93A-induced apoptosis via Bax–Bak interaction.
Figure 4: PSAP was involved in SOD1G93A-induced Bax–Bak complex formation required for SOD1G93A-induced apoptosis. (A) Both wtSOD1 and SOD1G93A complexed with Bax and Bak and induced the formation of PSAP-Bax, PSAP-Bak, or Bax-Bak complexes. The cell lysates were immunoprecipitated after transfection with LacZ (lane 2), wtSOD1 (lane 3), or SOD1G93A (lane 4) using anti-Myc antibodies. Immunoprecipitations were probed with anti-Bax (top panel) or anti-Bak (Panel 2) antibodies. The cell lysates were also immunoprecipitated with anti-PSAP antibodies and probed with anti-Bax (Panel 3) and anti-Bak antibodies (Panel 4). Finally, the cell lysates were immunoprecipitated with anti-Bax antibodies and probed for Bak (bottom panel). Lane 1: positive control. Lane 7: SOD1G93A-transfected cells were immunoprecipitated with IgG as a negative control. (B) As indicated, NSC-34 cells were transiently transfected with LacZ (lanes 2 and 5), wtSOD1 (lanes 3 and 6), or SOD1G93A(lanes 4 and 7), respectively 48 h after the transfection of scrambled PSAP-specific siRNAs (lanes 5, 6, and 7).The cell lysates were immunoprecipitated using anti-Bax antibodies. Immunoprecipitations were probed with anti-Bak antibodies. Lane 1: positive control. Lane 8: SOD1G93A-transfected cells were immunoprecipitated with IgG as a negative control. (C) Top panel: knockdown efficiency of PSAP. Second panel: transfection efficiency of SOD1G93A using anti-flag antibodies. Bottom panel: GAPDH as a loading control. (D) Datapresented as mean ± SEM. ANOVA, *P < 0.05 compared with control.
This study demonstrated that a specific mitochondrial protein PSAP played an important role in SOD1G93A-induced apoptosis through Bax-Bak interaction. These findings provided new insights into the role of PSAP in motor neuron death and axon degeneration in ALS, highlighting the potential of PSAP as a novel therapeutic target for ALS treatment and prevention.
ALS is a neurodegenerative disease characterized by motor neuron death and axon degeneration that rapidly progresses after onset (Rowland and Shneider, 2001). Statistically, the average survival time of patients with ALS is ∼18 months (Bonafede et al., 2016). Studies have shown that oxidative stress, excitotoxicity, inflammation, and apoptosis can induce ALS (Krishnaraj et al., 2016). The mechanisms of motor neuron death remain unclear, and hence current therapeutic strategies are limited. Riluzole and edaravone are approved by the Food and Drug Administration for treating ALS (Dash et al., 2018; Jaiswal, 2019). Although they delay the development of ALS and prolong the life of patients by months, the benefits are negligible. Huang et al. (2013) demonstrated that DR6 was involved in the etiology of motor neuron death and axon degeneration, and that blocking DR6 with antibodies promoted motor neuron survival, improved motor neuron function, and protected neuromuscular junction integrity. Further evidence indicated that DR6 played a pivotal role in neuronal cell death and induced apoptosis through its interaction with Bax via a unique mitochondrial pathway (Zeng et al., 2012).
PSAP, also known as mitochondrial carrier homolog 1 (MTCH1) due to its homology with a mitochondrial carrier protein, was identified as a specific mitochondrial resident protein and shown to induce apoptosis via Apaf-1 and Smac (Li et al., 2013). Another mitochondrial carrier homolog, mitochondrial carrier homolog 2 (MTCH2), also known as met-induced mitochondrial protein, has been reported to interact with tBid in the mitochondria, forming a protein complex containing Bax (Lamarca et al., 2008). PSAP is the key to enhancing the function of the permeability transition pore (MOMP), which is a target of mitochondrial pro-apoptotic proteins or other related proteins. However, the mechanism(s) by which PSAP regulates mitochondrial apoptosis remains elusive (Lamarca, et al., 2008). Previous data demonstrated that PSAP -Bax complex formation was detected on the overexpression of DR6 or following Tumor Necrosis Factor α (TNFα) (Zhang et al., 2020). More interestingly, PSAP was crucial for DR6-induced apoptosis. DR6 triggered PARP cleavage, caspase activation, Cyt C release, and Bax translocation following PSAP silencing in vitro. Transgenic mice carrying mutant human SOD1, particularly human SOD1G93A, were similar to patients with ALS in the clinic and hence could be used as reliable fALS models to dissect the mechanisms of cell death (Xie et al., 2015). Thus, NSC-34 cells were transfected with SOD1G93A to serve as an ALS cell model in vitro. PSAP specifically localized on the mitochondria, and Bcl-2 family members, including Bax and Puma, were associated with the pathology of ALS (Gould et al., 2006; Kieran et al., 2007). The study first examined the role of Bcl-2 family members in SOD1G93A-induced apoptosis. CCK-8, PARP cleavage, and Annexin V/PI double staining showed that both Bax and Bak played important roles in SOD1-induced apoptosis, as SOD1G93A-induced cell death was inhibited by Bax or Bak silencing. The study assessed cell activity via CCK-8 assay, PARP cleavage via Western blot analysis, and Annexin V/PI staining via flow cytometry using PSAP siRNA to determine the effects of PSAP on ALS. Similar to DR6, the silencing of PSAP attenuated SOD1G93A-induced apoptosis.
Oxidative stress, excitotoxicity, inflammation, loss of growth factors, and apoptosis induced ALS. Interestingly, these processes were either directly or indirectly related to mitochondrial function. Mitochondria are crucial for ATP production through oxidative phosphorylation and are critical for neuronal function. Mitochondrial dysfunction results in the loss of ATP production and reactive oxygen species (ROS) generation, promoting cell death. Mitochondrial damage therefore leads to neurodegenerative diseases (Xie et al., 2015). Mutant SOD1 was first identified by Rosen et al. in 1993 and was shown to be involved in ALS. To date, ≥130 mut SODl cell and animal models have been established for clinical research and drug development. Despite the initial promise, SOD1 gene therapy for patients with ALS has proved ineffective. SOD1G93A and other mutation models still hold an important research value because ALS is not a simple motor neuron disease, as changes in non-motor neuron cells also contribute to disease pathogenesis (Reyes et al., 2010). ALS-related genes, including wtSOD1 and mutSOD1, are associated with mitochondrial dysfunction (Cozzolino et al., 2013; Xie, et al., 2015). The key mitochondrial regulatory factors, the Bcl-2 family, also play an important role in SOD1G93A-induced apoptosis, including Bax and Bak, which regulate the intrinsic mitochondrial apoptosis pathway. Bax and Bak shuttle between the cytosol and the mitochondria outer membrane (MOM) in healthy cells (Todt et al., 2015). In response to an apoptotic stimulus, Bax and Bak are activated and accumulate on the MOM, triggering MOMP, leading to Cyt C release, capsase activation, and apoptosis (Pena-Blanco and Garcia-Saez, 2018). In addition, the mitochondrial apoptosis -induced channel (MAC) was identified as an outer membrane channel associated with apoptosis, although the role of Bax and Bak in MAC regulation remains undefined (Kroemer et al., 2007).
IP was performed to determine the relationship between SOD1, PSAP, Bax, and Bak so as to further explore the mechanism of PSAP regulating SOD1G93A-induced apoptosis. A higher number of SOD1 -Bax complexes were evident after the overexpression of wtSOD1, while SOD1 -Bax complex formation decreased in response to SOD1G93A overexpression. Bax translocation from the cytosol into the mitochondria was also observed in SOD1G93A but not wtSOD1-overexpressing cells. Generally, SOD1 localized to the cytosol, and SOD1 -Bax complexes were abundant following wtSOD1 transfection. Higher levels of Bax translocated into the mitochondria; SOD1G93A transfection explained the decreased SOD1-Bax interaction observed in cells expressing this mutant. The overexpression of SOD1 could disrupt Bax-Bak, PSAP-Bax, and PSAP-Bak complex formation in wtSOD1-transfected cells. In contrast, only slight differences in PSAP-Bax or PSAP-Bak complex formation were observed on SOD1G93A overexpression. However, SOD1G93A dramatically increased the number of Bax-Bak complexes, thereby promoting apoptosis. Furthermore, the knockdown of PSAP inhibited SOD1G93A-induced Bax-Bak complex formation. These data suggested that PSAP regulated the formation of the Bax-Bak complex, either directly or indirectly, and mediated its effects on apoptotic induction through MOMP.
In summary, the results indicated that the mitochondrial protein PSAP was required for SOD1G93A-induced apoptosis mediated through mitochondrial apoptosis-induced channels. PSAP is pivotal for Bax-Bak interaction, leading to caspase activation and apoptosis. Inhibiting these activities of PSAP therefore represents a potential approach for treating ALS.
Abbreviations: ALS, Amyotrophic lateral syndrome; Cyt C, cytochrome c; DR6, death receptor 6; PS1, presenilin 1; PSAP, PS1-associated protein; SOD1, superoxide dismutase 1; Bax, Bcl2-Associated X; Puma, P53 up-regulated modulator of apoptosis.
Availability of Data and Material: All data generated or analyzed during this study are included in this published article.
Author Contribution: Study conception and design: Linlin Zeng, Fuqiang Zhang. Performed the experiments: Han Niu, Xin Chen, Jingtian Zhang, Yuxiang Wang, Jiayue Song, Yu Wang. Data collection: Han Niu, Xin Chen, Jingtian Zhang. Analysis and interpretation of results: Han Niu, Xin Chen, Xueting Ma, Xueqi Fu, Chen Hu, Xuemin Xu. Funding acquisition: Guodong Li, Fuqiang Zhang, Linlin Zeng. Writing-Original draft preparation: Linlin Zeng, Han Niu. Writing-Reviewing and editing: Fuqiang Zhang, Xueqi Fu, Xuemin Xu.
Funding Statement: This study was supported by grants from the National Natural Science Foundation of China [Grant No. 81701076, Linlin Zeng], the Science and Technology Department of Jilin Province [Grant No. 20190701037GH, Fuqiang Zhang; Grant No. 20190701036GH, Linlin Zeng; and Grant No. 20200201386JC, Guodong Li], the Education Department of Jilin Province [Grant No. JJKH20200948KJ, Linlin Zeng]. The funding bodies played no role in study design, collection, analysis, and interpretation of data; writing of the report; and decision to submit the manuscript for publication.
Conflicts of Interest: The authors declare that they have no conflicts of interest to report regarding the present study.
Alonso A, Logroscino G, Jick SS, Hernan MA (2009). Incidence and lifetime risk of motor neuron disease in the United Kingdom: A population-based study. European Journal of Neurology 16: 745–751. DOI 10.1111/j.1468-1331.2009.02586.x. [Google Scholar] [CrossRef]
Bonafede R, Scambi I, Peroni D, Potrich V, Boschi F, Benati D, Bonetti B, Mariotti R (2016). Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Experimental Cell Research 340: 150–158. DOI 10.1016/j.yexcr.2015.12.009. [Google Scholar] [CrossRef]
Chaturvedi RK, Beal MF (2013). Mitochondria targeted therapeutic approaches in Parkinson’s and Huntington’s diseases. Molecular and Cellular Neuroscience 55: 101–114. DOI 10.1016/j.mcn.2012.11.011. [Google Scholar] [CrossRef]
Chen DF, Schneider GE, Martinou JC, Tonegawa S (1997). Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385: 434–439. DOI 10.1038/385434a0. [Google Scholar] [CrossRef]
Cozzolino M, Ferri A, Valle C, Carri MT (2013). Mitochondria and ALS: Implications from novel genes and pathways. Molecular and Cellular Neuroscience 55: 44–49. DOI 10.1016/j.mcn.2012.06.001. [Google Scholar] [CrossRef]
Dash RP, Babu RJ, Srinivas NR (2018). Two decades-long journey from riluzole to edaravone: Revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics. Clinical Pharmacokinetics 57: 1385–1398. DOI 10.1007/s40262-018-0655-4. [Google Scholar] [CrossRef]
Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, Oppenheim RW (2006). Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. Journal of Neuroscience 26: 8774–8786. DOI 10.1523/JNEUROSCI.2315-06.2006. [Google Scholar] [CrossRef]
Huang G, Lee X, Bian Y, Shao Z, Sheng G, Pepinsky RB, Mi S (2013). Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis. Cell Death & Disease 4: e841. DOI 10.1038/cddis.2013.378. [Google Scholar] [CrossRef]
Jaiswal MK (2019). Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Medicinal Research Reviews 39: 733–748. DOI 10.1002/med.21528. [Google Scholar] [CrossRef]
Kieran D, Woods I, Villunger A, Strasser A, Prehn JH (2007). Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proceedings of the National Academy of Sciences of the United States of America 104: 20606–20611. DOI 10.1073/pnas.0707906105. [Google Scholar] [CrossRef]
Krishnaraj RN, Kumari SSS, Mukhopadhyay SS (2015). Antagonistic molecular interactions of photosynthetic pigments with molecular disease targets: a new approach to treat AD and ALS. Journal of Receptors and Signal Transduction 36: 67–71. DOI 10.3109/10799893.2015.1024851. [Google Scholar] [CrossRef]
Kroemer G, Galluzzi L, Brenner C (2007). Mitochondrial membrane permeabilization in cell death. Physiological Reviews 87: 99–163. DOI 10.1152/physrev.00013.2006. [Google Scholar] [CrossRef]
Lamarca V, Marzo I, Sanz-Clemente A, Carrodeguas JA (2008). Exposure of any of two proapoptotic domains of presenilin 1-associated protein/mitochondrial carrier homolog 1 on the surface of mitochondria is sufficient for induction of apoptosis in a Bax/Bak-independent manner. European Journal of Cell Biology 87: 325–334. DOI 10.1016/j.ejcb.2008.02.004. [Google Scholar] [CrossRef]
Li T, Zeng LL, Gao W, Cui MZ, Fu XQ, Xu XM (2013). PSAP induces a unique Apaf-1 and Smac-dependent mitochondrial apoptotic pathway independent of Bcl-2 family proteins. Biochimicaet Biophysica Acta 1832: 453–474. [Google Scholar]
Mao G, Tan J, Gao W, Shi Y, Cui MZ, Xu X (2008). Both the N-terminal fragment and the protein-protein interaction domain (PDZ domain) are required for the pro-apoptotic activity of presenilin-associated protein PSAP. Biochimcaet Biophysica Acta 1780: 696–708. [Google Scholar]
Pasinelli P, Brown RH (2006). Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nature Reviews Neuroscience 7: 710–723. DOI 10.1038/nrn.1971. [Google Scholar] [CrossRef]
Pena-Blanco A, Garcia-Saez AJ (2017). Bax, Bak and beyond-mitochondrial performance in apoptosis. FEBS Journal 285: 416–431. DOI 10.1111/febs.14186. [Google Scholar] [CrossRef]
Reyes NA, Fisher JK, Austgen K, VandenBerg S, Huang EJ, Oakes SA (2010). Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. Journal of Clinical Investigation 120: 3673–3679. DOI 10.1172/JCI42986. [Google Scholar] [CrossRef]
Rowland LP, Shneider NA (2001). Amyotrophic lateral sclerosis. New England Journal of Medicine 344: 1688–1700. DOI 10.1056/NEJM200105313442207. [Google Scholar] [CrossRef]
Todt F, Cakir Z, Reichenbach F, Emschermann F, Lauterwasser J, Kaiser A, Ichim G, Tait SW, Frank S, Langer HF, Edlich F (2015). Differential retrotranslocation of mitochondrial Bax and Bak. EMBO Journal 34: 67–80. DOI 10.15252/embj.201488806. [Google Scholar] [CrossRef]
Wang H, Yi J, Li X, Xiao Y, Dhakal K, Zhou J (2018). ALS-associated mutation SOD1 (G93A) leads to abnormal mitochondrial dynamics in osteocytes. Bone 106: 126–138. DOI 10.1016/j.bone.2017.10.010. [Google Scholar] [CrossRef]
Xie Y, Zhou B, Lin MY, Wang S, Foust KD, Sheng ZH (2015). Endolysosomal deficits augment mitochondria pathology in spinal motor neurons of asymptomatic fALS mice. Neuron 87: 355–370. DOI 10.1016/j.neuron.2015.06.026. [Google Scholar] [CrossRef]
Xu X, Yokoyama S, Hayakawa Y, Saiki I (2017). CoptidisRhizoma induces intrinsic apoptosis through BAX and BAK activation in human melanoma. Oncology Reports 38: 538–544. DOI 10.3892/or.2017.5672. [Google Scholar] [CrossRef]
Zeng LL, Li T, Xu DC, Liu J, Mao G, Cui MA, Fu XQ, Xu XM (2012). Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein. Journal of Biological Chemistry 287: 29125–29133. DOI 10.1074/jbc.M112.362038. [Google Scholar] [CrossRef]
Zhang JT, Zhao JZ, Fu XQ, Niu H, Hu C, Dong Y, Cui MZ, Zhang FQ, Zeng LL, Xu XM (2020). Proapoptotic mitochondrial carrier homolog protein PSAP mediates death receptor 6 induced apoptosis. Journal of Alzheimer’s Disease 74: 1097–1106. DOI 10.3233/JAD-191086. [Google Scholar] [CrossRef]
 | This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |